| |
|
|
|
Aldeyra Therapeu  
|
|
6.78 -0.36 (-0.05%) |
09-23 16:00 |
|
Open: |
7.1 |
Pre close: |
7.14 |
Target:
|
8.82
|
|
High: |
7.26 |
Low: |
6.72 |
Resistance:
|
7.55
8.82
|
|
Volume: |
435,806 |
Market Cap: |
262M |
Support:
|
6.30
5.53
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.09
 |
MACD |
MACD(12,26):
|
0.14 |
|
MA(20): |
6.72 |
Signal(12,26,9): |
0.13  |
|
MA(100): |
5.50 |
Stochastic Oscillator |
%K(14,3):
|
73.30 |
|
MA(250): |
5.07 |
%D(3): |
81.30 |
|
Average Volume(K) |
3-Month: |
108085
|
52-Week |
High:
|
8.05 |
|
10-Days: |
71462 |
Low: |
1.48 |
|
RSI |
RSI(14):
|
50.14 |
Change(%): |
20.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.730 |
Return on Equity (ttm) |
-82.0 |
Shares Out. (M) |
38.63 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-41.8 |
Shares Float (M) |
38.05 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.01 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.87 |
|
Forward EPS |
-2.240 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
817 |
|
Book Value (p.s.) |
1.600 |
EBITDA (p.s.) |
-1.254 |
P/E |
-3.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-42.48 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.20 |
P/CF |
-6.17 |
|
|
|
|
|
|
